USRM
US Stem Cell Inc

269
Loading...
Loading...
U.S. Stem Cell, Inc. is a biotechnology company, which engages in the discovery, development, and subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its product, MyoCell, deals with the clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. The company was founded by Howard J. Leonhardt and Robert D. Lashinski on August 12, 1999 and is headquartered in Sunrise, FL.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of U.S. Stem Cell Inc?
What is the 52-week high for U.S. Stem Cell Inc?
What is the 52-week low for U.S. Stem Cell Inc?
What is U.S. Stem Cell Inc stock price today?
What was U.S. Stem Cell Inc stock price yesterday?
What is the 50-day moving average of U.S. Stem Cell Inc?

Latest USRM News

View
No USRM news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.